ARCHIVES

Cancer Advocates Use Benefit Analysis To Press For Funds

This article is from The Cancer Letter archive.

Vol. 16 No. 19 | May 11, 1990

Download PDF Visit The Full Archive

Related Articles

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

Senate Passes Extension Ac; Kennedy Plans Saccharin Hearing

May 13, 1977

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

The Avastin Story In A Nutshell: A Timeline

May 27, 2011

Two Trials Presented at ASCO Demonstrate Drop in Death Risk, Increased Survival

June 24, 2011

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

May 31, 1996